Moreover, Özverel et al. [34], reported that Mice treated with HER2/neu-loaded DCs vaccine combined with QS-21 and anti-PD-L1 mAb had significantly decreased tumor sizes, compared to mice treated with vaccine alone. The gene discussed is ERBB2; the disease is neoplasm.